Physician

Alexandra Elizabeth Bursic, MD

According to 2025 Medicare claims, Alexandra Bursic, MD (NPI: 1629568282) practices nephrology in the Pittsburgh, PA market, with the plurality of this provider's patient population coming from Allegheny, PA. This provider's primary affiliated billing organization is UNIVERSITY OF PITTSBURGH PHYSICIANS (NPI: 1326058553; TIN: 232919472) and primary practice location at 15213-2536.

Bursic's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 161 traditional Medicare patients, billed 409 HCPCS/CPT codes, and received $28,856 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 384 prescription claims across 94 beneficiaries totaling $37,637 in drug costs, led by Jardiance (Empagliflozin). Open Payments data shows 2 records totaling $131. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $921 to $37,637. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$14K$29K2023 Medicare payment: $13,570 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $28,856 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
202369177$13,570
2024161409$28,856

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$19K$38K2018 Drug cost: $921 (USD; Tot_Drug_Cst)2019 Drug cost: $5,606 (USD; Tot_Drug_Cst)2020 Drug cost: $3,669 (USD; Tot_Drug_Cst)2021 Drug cost: $310 (USD; Tot_Drug_Cst)2023 Drug cost: $2,139 (USD; Tot_Drug_Cst)2024 Drug cost: $37,637 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
20181131$921
20191230$5,606
20201848$3,669
2021N/R18$310
2022N/RN/RN/R
20232557$2,139
202494384$37,637

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more2024$127
99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes2525$91
99232Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes59124$58
90935Hemodialysis procedure with physician evaluation3791$52
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's2729$12

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
JardianceEmpagliflozin11510$9,450
BumetanideBumetanide23976$860
Nifedipine ErNifedipine201,076$426
Losartan PotassiumLosartan Potassium462,685$372
CarvedilolCarvedilol342,084$343

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.2$131Vifor Pharma, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Alexandra Elizabeth Bursic, MD?

Tedicare shows public-source Medicare data for Alexandra Elizabeth Bursic, MD (NPI 1629568282), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alexandra Elizabeth Bursic, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Alexandra Elizabeth Bursic, MD?

Alexandra Elizabeth Bursic, MD is linked to UNIVERSITY OF PITTSBURGH PHYSICIANS (billing NPI 1326058553) in the available physician profile data.

Does Alexandra Elizabeth Bursic, MD have Open Payments data?

Alexandra Elizabeth Bursic, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.